Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity
SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC...
SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC...
CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering...
MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in...
SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC...
MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in...
Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...
Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...
Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis...
Dr. Javad Sajan at Allure Esthetic is the best facial feminization surgeon in the U.S. SEATTLE, WA / ACCESS Newswire...
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every...
SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc. (Nasdaq: VSEE) (the "Company"), a provider...
In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer...
Recognition in breast augmentation and liposuction highlights Dr. Doherty's expertise in two of the most requested cosmetic procedures, underscoring his...
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell...
FREDERICK, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
FRAMINGHAM, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Alira Health announced today that it has become the first Platinum CRO...
MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in...
TORONTO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) (“Ultrack” or the “Company”), through its wholly owned...
Funding supports Phase 2b development of clofutriben, a novel HSD-1 inhibitor, with a focus on cortisol-driven metabolic dysfunction in type...
Intends to Initiate Phase 1b Clinical Trial in TNBC at Mayo Clinic in Fourth Quarter 2025FLORHAM PARK, N.J. and LONDON...